Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts

Mark A. Stein, Irwin D. Waldman, Elizabeth Charney, Subhash Aryal, Craig Sable, Reut Gruber, Jeffrey H. Newcorn

Research output: Contribution to journalArticle

53 Scopus citations

Abstract

Objective: To compare the dose effects of long-acting extended-release dexmethylphenidate (ER d-MPH) and ER mixed amphetamine salts (ER MAS) on attention-deficit/hyperactivity disorder (ADHD) symptom dimensions, global and specific impairments, and common adverse events associated with stimulants. Methods: Fifty-six children and adolescents with ADHD participated in an 8-week, double-blind, crossover study comparing ER d-MPH (10, 20, 25-30 mg) and ER MAS (10, 20, 25-30) with a week of randomized placebo within each drug period. Efficacy was assessed with the ADHD Rating Scale-IV (ADHD-RS-IV), whereas global and specific domains of impairment were assessed with the Clinical Global Impressions Severity and Improvement Scales and the parent-completed Weiss Functional Impairment Scale, respectively. Insomnia and decreased appetite, common stimulant-related adverse events, were measured with the parent-completed Stimulant Side Effects Rating Scale. Results: Both ER d-MPH and ER MAS were associated with significant reductions in ADHD symptoms. Improvement in Total ADHD and Hyperactivity/Impulsivity symptoms were strongly associated with increasing dose, whereas improvements in Inattentive symptoms were only moderately associated with dose. About 80% demonstrated reliable change on ADHD-RS-IV at the highest dose level of ER MAS compared with 79% when receiving ER d-MPH. Decreased appetite and insomnia were more common at higher dose levels for both stimulants. Approximately 43% of the responders were preferential responders to only one of the stimulant formulations. Conclusions: Dose level, rather than stimulant class, was strongly related to medication response.

Original languageEnglish
Pages (from-to)581-588
Number of pages8
JournalJournal of Child and Adolescent Psychopharmacology
Volume21
Issue number6
DOIs
StatePublished - 1 Dec 2011

Fingerprint Dive into the research topics of 'Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts'. Together they form a unique fingerprint.

  • Cite this